Albert J Chang Selected Research

Albert J Chang Research Topics

Disease

28	Prostatic Neoplasms (Prostate Cancer) 10/2023 - 06/2013
20	Neoplasms (Cancer) 09/2023 - 08/2004
5	Neoplasm Metastasis (Metastasis) 01/2021 - 02/2005
3	Urinary Bladder Neoplasms (Bladder Cancer) 01/2023 - 01/2016
3	Carcinoma (Carcinomatosis) 01/2023 - 11/2017
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2022 - 01/2012
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2018 - 09/2010
3	Colorectal Neoplasms (Colorectal Cancer) 03/2014 - 02/2005
2	Sarcoma (Soft Tissue Sarcoma) 01/2022 - 05/2019
2	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2012
2	Adenocarcinoma 03/2015 - 08/2004
1	Uveal melanoma 01/2022
1	Endometrial Neoplasms (Endometrial Cancer) 01/2022
1	Pain (Aches) 11/2021
1	Back Pain (Backache) 11/2021
1	Hemorrhage 06/2021
1	Pneumothorax 06/2021
1	Abscess 03/2018
1	Squamous Cell Carcinoma of Head and Neck 03/2013
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2013
1	Kidney Neoplasms (Kidney Cancer) 01/2013
1	Carcinogenesis 05/2006
1	Colonic Neoplasms (Colon Cancer) 08/2004
1	Hepatitis B 10/2003
1	Hepatitis C 10/2003

Drug/Important Bio-Agent (IBA)

3	AndrogensIBA 09/2022 - 03/2015
3	Peptides (Polypeptides)IBA 01/2014 - 08/2004
2	Hormones (Hormone)IBA 01/2023 - 02/2014
2	Androgen Antagonists (Antiandrogens)IBA 01/2023 - 09/2022
2	HydrogelsIBA 01/2022 - 03/2018
2	Prostate-Specific Antigen (Semenogelase)IBA 02/2017 - 10/2015
2	Antineoplastic Agents (Antineoplastics)IBA 01/2013 - 02/2005
2	GastrinsIBA 05/2006 - 08/2004
1	enzalutamideIBA 09/2022
1	Leuprolide (Lupron)FDA LinkGeneric 09/2022
1	gallium 68 PSMA-11IBA 01/2019
1	RadiumIBA 09/2018
1	AntigensIBA 01/2018
1	FluorineIBA 02/2017
1	fluorocholineIBA 02/2017
1	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 03/2014
1	Therapeutic UsesIBA 03/2014
1	CopperIBA 03/2014
1	RadiopharmaceuticalsIBA 03/2014
1	Copper-64IBA 03/2014
1	Radioisotopes (Radionuclides)IBA 03/2014
1	Chelating AgentsIBA 01/2014
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 03/2013
1	ErbB Receptors (EGF Receptor)IBA 01/2013
1	Bevacizumab (Avastin)FDA Link 01/2013
1	Everolimus FDA Link 01/2013
1	Angiogenesis InhibitorsIBA 01/2013
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2013
1	zirconium-89-trastuzumabIBA 01/2012
1	Trastuzumab (Herceptin)FDA Link 01/2012
1	human ERBB2 proteinIBA 01/2012
1	Monoclonal AntibodiesIBA 01/2012
1	PPAR gammaIBA 05/2006
1	Peroxisome ProliferatorsIBA 05/2006
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 02/2005
1	Ibuprofen (Motrin)FDA LinkGeneric 02/2005
1	Fluorouracil (Carac)FDA LinkGeneric 02/2005
1	Irinotecan (Camptosar)FDA LinkGeneric 02/2005
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 02/2005
1	rofecoxib (Vioxx)FDA Link 02/2005
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 08/2004
1	Cholecystokinin (Pancreozymin)IBA 08/2004
1	Cholecystokinin B ReceptorIBA 08/2004
1	Immunoglobulins (Immunoglobulin)IBA 10/2003
1	Lamivudine (Epivir)FDA Link 10/2003
1	hepatitis B hyperimmune globulinIBA 10/2003

Therapy/Procedure

28	Radiotherapy 09/2023 - 10/2011
17	Brachytherapy 10/2023 - 01/2012
13	Therapeutics 09/2023 - 02/2005
3	Aftercare (After-Treatment) 11/2021 - 03/2018
3	Catheters 06/2021 - 03/2015
3	Drug Therapy (Chemotherapy) 01/2018 - 09/2010
2	Prostatectomy (Retropubic Prostatectomy) 01/2023 - 02/2017
2	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2022 - 01/2012
1	Transurethral Resection of Bladder 01/2023
1	Re-Irradiation 11/2021
1	Chest Tubes (Chest Tube) 06/2021
1	Immunotherapy 01/2018
1	Transurethral Resection of Prostate (TURP) 11/2017
1	Cystectomy 01/2016
1	Liver Transplantation 10/2003
1	Transplantation 10/2003